Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-531011 + RadScopal in Previously Treated Metastatic Colorectal Cancer
NCT07720115Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2026
- Primary completion
- Sep 2026
01
Overview
A Phase 2 trial of S-531011 in colorectal cancer (CRC), sponsored by University of Texas MD Anderson Cancer Center. Planned start Aug 2026; status: withdrawn.
02
Drugs
S-531011
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07720115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07720115.